|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Sickle Cell Anemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Anemia, Sickle Cell | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia | |||||
| Anemia, Hemolytic | |||||
| Anemia, Hemolytic, Congenital | |||||
| Genetic Diseases, Inborn | |||||
| Hematologic Diseases | |||||
| Hemoglobinopathies | |||||
| 4 | Interventions listed in this trial | ||||
| cyclosporine | |||||
| fludarabine | |||||
| mycophenolate mofetil | |||||
| Bone Marrow Transplantation | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Cyclosporins | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antifungal Agents | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Dermatologic Agents | |||||
| Enzyme Inhibitors | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Fred Hutchinson Cancer Research Center | |||||